In the past 10 years, there has been a lot of enthusiasm surrounding the use of serum
hepatitis B surface antigen (HBsAg) quantification to predict disease activity and monitor …

Currently, despite the use of a preventive vaccine for several decades as well as the use of
effective and well-tolerated viral suppressive medications since 1998, approximately 250 …

Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest
rates of infection in Africa and Asia. Our understanding of the natural history of HBV infection …

Background & Aims It has been proposed that serum hepatitis B core-related antigen
(HBcrAg) reflects intrahepatic covalently closed circular (ccc) DNA levels. However, the …

Large volume of new data on the natural history and treatment of chronic hepatitis B virus
(HBV) infection have become available since 2008. These include further studies in …

BACKGROUND & AIMS: Patients with chronic hepatitis B virus (HBV) infection have a high
risk for developing hepatocellular carcinoma (HCC). Patients with lower levels of hepatitis B …

Diseases (AASLD) also presented and continued to revise their clinical practice guidelines,
and the latest updates were in 2015, 2017, and 2018. However, since the medical …

Background & Aims Chronic hepatitis B virus (HBV) infection is characterized by the
presence of defective viral envelope proteins (hepatitis B surface antigen [HBsAg]) and the …

Integrating host and HBV characteristics, this study aimed to develop models for predicting
long‐term cirrhosis and hepatocellular carcinoma (HCC) risk in chronic hepatitis B virus …

Quantitative HBsAg had been suggested to be helpful in management of HBV, but assays
were cumbersome. The recent availability of commercial quantitative assays has restarted …